- Virtual Realities Against Pain By : Medical News
The feeling of pain produced during medical treatment can be reduced through sophisticated virtual reality helmets, a simple computer game and the determined predisposition of the patient. According to research psychologists at the UAB, this type of distraction even reduces the dosage of sedatives. Their research suggests putting greater emphasis on methodology and on psychological aspects of this technique in order to improve its property. - New ITI Study Shows Potential Of Intranasal Midazolam As An Effective, Noninvasive Sedative By : Medical News
Intranasal Therapeutics, Inc. (ITI) announced today that a proof-of-principle study published in the August issue of the peer-reviewed journal Anesthesia & Analgesia demonstrates the potential of intranasally delivered midazolam as a convenient, fast-acting and noninvasive alternative to intravenous and oral forms of this widely used sedative. - DOV Pharmaceutical, Inc. Announces Results Of Carcinogenicity Studies By : Medical News
DOV Pharmaceutical, Inc. (Nasdaq: DOVP) announced today the completed assessment of results from the carcinogenicity studies for its novel analgesic, bicifadine. There were no meaningful signals of carcinogenicity detected after two years of testing in two species -- rats and mice. The Company believes these results are very positive, as this outcome from these two important safety studies will support the ability of DOV to file an NDA with the U.S. - Lower Levels Of Anti-inflammatory Proteins May Contribute To Chronic Widespread Pain By : Medical News
Chronic widespread pain, a common medical condition, can be difficult to treat and is often associated with fatigue, poor sleep and depression. A connection between fibromayalgia (FM) and cytokines (proteins that act as messengers between cells) was suspected after cancer patients treated with the cytokine interleukin -2 developed FM-like symptoms. - Back Pain A Common Problem For Nurses By : Medical News
Nurses offer care and comfort, but they often end up with a pain in the back for their efforts, the results of a new study show.
"Nurses suffer from work-related low back pain more often than workers in other professions," said Edgar Vieira, a doctoral student in the University of Alberta Faculty of Rehabilitation Medicine and lead author of the study. - HEALTHPOINT's Proprietary EXACTACAIN(TM) Spray Topical Anesthetic Can Reduce Risk Of Benzocaine By : Medical News
A 2006 FDA advisory about the dangers associated with possible overdosing and erroneous administration of benzocaine products highlights the value of one product that may be a safer dosing alternative for physicians and their patients --- HEALTHPOINT's EXACTACAIN(TM) (benzocaine 14%, butamben 2%, tetracaine hydrocholoride 2%) Spray Topical Anesthetic. - Effective Lower Back Pain Treatment By : Morgan Hamilton
I first recall having back pains in October of 2004. On the outset it was nothing more than a minor irritant after having sat for too long. It is now become much more than that. I am definitely in one of the risk groups for needing lower back pain treatment. My problem is pretty much brought on by my own doing. I do not exercise nearly as much as I should. - Back Pain Treatment & Exercise & Tips By : Mohammed Abdulaleem
Approximately 80% people living in USA suffer from back pain above the age of 40 . for those whose job is glued to computer without taking proper care or exercise are under the risk of Back pain. - Back Pain and Tens Units By : Lenore Chapman
Do you have constant back pain and don't know how to relieve it? Well, try a Tens Unit. I have constant back pain, and I do the ice pack for twenty minutes and then a heating pad for twenty minutes. - ORADUR(TM) Technology Milestone: New ORADUR-based Investigational Drug Candidate Commences Phase I By : Medical News
DURECT Corporation (Nasdaq: DRRX) reported today the initiation of a Phase I clinical trial for a new ORADUR-based opioid drug candidate. This new drug candidate is the second ORADUR-based opioid drug to undergo clinical testing by King Pharmaceuticals, Inc., the company which will be commercializing the drug candidate, if approved, and Pain Therapeutics, Inc. - Pain Therapeutics And King Pharmaceuticals Initiate Clinical Program Of A Second Abuse-Resistant By : Medical News
Pain Therapeutics, Inc. (Nasdaq: PTIE) and King Pharmaceuticals, Inc. (NYSE: KG) announced today the initiation of a Phase I clinical trial to evaluate the effects of PTI-202 in humans. PTI-202 is a new drug candidate in the companies' collaboration to develop abuse-resistant opioid painkillers, a new category of drugs intended to prevent prescription drug abuse. - Glimmer Of Hope For Gout Patients By : Medical News
For over 100 years we have known that the intensely painful disease gout is caused by the accumulation of monosodium urate crystals (MSU) in joints. Now, in a study appearing in the August issue of the Journal of Clinical Investigation, Kenneth Rock and colleagues from University of Massachusetts Medical School uncover how these crystal deposits are recognized by the immune system and trigger acute and painful inflammation. - Glimmer Of Hope For Gout Patients By : Medical News
For over 100 years we have known that the intensely painful disease gout is caused by the accumulation of monosodium urate crystals (MSU) in joints. Now, in a study appearing in the August issue of the Journal of Clinical Investigation, Kenneth Rock and colleagues from University of Massachusetts Medical School uncover how these crystal deposits are recognized by the immune system and trigger acute and painful inflammation. - Gout Increases Risk Of Heart Attack, According To University Of Pittsburgh Study By : Medical News
People with gout are at increased risk of having a heart attack, according to a University of Pittsburgh School of Medicine study published in the August edition of the journal Arthritis & Rheumatism. The article is available on line at http://www3.interscience.wiley.com/cgi-bin/jhome/76509746. This is the first study to show that among men with no previous history of coronary artery disease, gout is a significant independent risk factor of heart attack. - Investigational Drug Targeting Inflammatory Bowel Disease Enters Second Human Clinical Trial By : Medical News
Novogen Limited's investigational anti-inflammatory compound NV-52, is entering its second human clinical study following the successful completion of toxicology testing.
NV-52 is a novel compound developed by Novogen to target inflammatory bowel disease.
This study was cleared to begin following the successful completion of a Phase Ia study that confirmed the bio-availability of the drug in oral form, and its safety when administered at an acute dose. - Pharmos Commences Dosing In Second Phase 2a Study Of Cannabinor In Experimentally Induced Pain By : Medical News
Pharmos Corporation (Nasdaq: PARS) announced today that it has commenced dosing in a second Phase 2a clinical study of cannabinor (PRS-211,375) for the treatment of pain. The proof-of-concept trial will test for analgesic activity and the safety of cannabinor, a CB2-selective synthetic cannabinoid drug candidate, in healthy subjects experiencing capsaicin-induced pain. - Benefit Of Yoga For Back Pain By : Jakob Culver
Do you have problems with back pain? Well there are many different ways to help control back problems and pain, however yoga has proven to be one of the best ways. Give it a go and relieve that pain in your back. - Digital Cameras And Internet Ease The Pain Of Oral Disease For Toddlers By : Medical News
Dental researchers are combining the ease of digital photography with the Internet to develop a new and inexpensive way to screen for a common childhood oral disease that predominantly plagues America's inner city toddlers - early childhood dental caries (ECC), or as it is commonly called, "baby bottle tooth decay." - NatureWell, Incorporated To Attend Annual American Association Of Naturopathic Physician Convention By : Medical News
NatureWell, Incorporated (the "Company") (OTC Bulletin Board: NAWL), announced today that it will be an exhibitor at the American Association of Naturopathic Physicians (AANP) Annual Convention in Portland, Oregon on August 10-12, 2006, where it will be marketing its natural migraine medication, MigraSpray. Located in Washington, DC and founded in 1985, the AANP is the foremost national professional society representing more than 2000 licensed or licensable naturopathic physicians. - Massage Therapy - is this a Good Way for Treating Back Pain? By : Kerris Samson
Article providing on how massage therapy is helpful in helping to relieve back pain. - Milestone Scientific Receives FDA Clearance Of Single Tooth Anesthesia Device By : Medical News
Milestone Scientific Inc. (Amex: MSS), which develops, manufactures, and markets 'intelligent' computer controlled local anesthetic delivery systems, today announced that it has received FDA 510(k) Premarket Notification clearance for the marketing and sale of its Single Tooth Anesthesia Device (STA). - Qualitative Review Of Chronic Lower Back Pain Clinical Studies Finds Minimally Invasive Procedure By : Medical News
A systematic literature review of outcomes from 51 clinical studies and case series finds that the Intradiscal ELECTROTHERMAL(TM) Therapy (IDET(TM)) procedure would spare up to 65 percent of patients with chronic lower back pain from spinal fusion surgery. In addition, the study also found that IDET patients experienced similar outcome benefits when compared against spinal fusion. - Clinical Review Of Minimally Invasive IDET(TM) Procedure Demonstrates Significant Decrease By : Medical News
A meta-analysis of the Intradiscal ELECTROTHERMAL(TM) Therapy (IDET(TM)) procedure examining outcomes of 17 clinical studies demonstrates that patients suffering from chronic disc-related low back pain experience a significant decrease in pain and improvement in physical function, as well as a low incidence of complications. The study is published in the July/August issue of Pain Medicine, the peer-reviewed journal of the American Academy of Pain Medicine. - Low Back Pain By : Shmuel Tatz
Back pain is number one condition in muscular-skeletal problems. It is degenerative condition in intervertebral discs, which result in decrease discs amortization ability and compress the nerve. In big amount of cases pain is related to disc herniation. As many as 8 of 10 Americans will experience lower back problems in their lives. On any given day, over 6.5 million Americans are under some sort of treatment for low back pain. The overall amount of money every year spend for this condition excides 16 billion dollars. - For UK Kids, TV An "Effective Painkiller" By : Anesthetics News
TV really does act like a painkiller when it comes to kids, reveals a small study published ahead of print in the Archives of Disease in Childhood. - Lower Back Pain: How Can We Help to Relieve It? By : Kerris Samson
This article is written by some one who over the years has suffered from lower back pain and has found other ways of treating the ailment. - Back Pain By : Marcus Peterson
Pain is experienced by everyone and is usually manifested with trauma, to a certain part of the body. It is basically the transmission of the nerves, communicating and passing nerve messages through the neurons. - FDA Approves ProDisc-L for Treatment of Low Back Pain By : Health News
Texas Back Institute's Center for Spine Arthroplasty announced today that the U.S. Food and Drug Administration (FDA) has approved the Synthes' ProDisc-L device, an artificial disc used to replace damaged or worn out discs in order to treat severe low back pain. Since Texas Back Institute (TBI) surgeon, Jack E. Zigler, M.D., performed the first ProDisc-L implant in the U.S. in October 2001. - Wyeth And Progenics Pharmaceuticals Announce Initiation Of Phase 2 Clinical Trial By : Anesthetics News
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced the initiation of a phase 2 clinical trial to evaluate once-daily dosing of oral methylnaltrexone. This trial is designed to identify the dose(s) of methylnaltrexone to be taken forward into the phase 3 clinical studies that will evaluate the efficacy. - "Mint" Pain Killer Takes Leaf Out Of Ancient Medical Texts By : Anesthetics News
A new synthetic treatment inspired by ancient Greek and Chinese remedies could offer pain relief to millions of patients with arthritis and nerve damage, a new University of Edinburgh study suggests. - TV Effective “ Painkiller” For Kids By : Anesthetics News
TV really does act like a painkiller when it comes to kids, reveals a small study published ahead of print in the Archives of Disease in Childhood. - Acupuncture Reduces Chronic Neck Pain; Massage Benefits Still Unclear By : Anesthetics News
Acupuncture offers relief from chronic neck pain, while there is little reliable evidence on the effectiveness of massage, according to two new systematic reviews. - The Truth About Sciatica Back Pain By : Korie Jacobs
Are you sick and tired of sciatica back pain? - Study Points To Better Numbing Medicine For Kids Getting IV Sticks By : Anesthetics News
When a child needs to be treated with IVs, numbing the skin in advance can help ease or eliminate the pain of needle insertion, making the procedure easier for the child, parents and health care professionals. - Director Of Foot And Ankle Center Says Options Abound To Treat Chronic Foot Pain By : Anesthetics News
Author Dianna Edwards and her husband enjoy active vacations, from exploring Mayan and Aztec ruins in Mexico to taking walking tours through Scotland. So when chronic foot pain sidelined her after bunion surgery, Edwards began an extensive search for medical options to end her pain and restore her mobility. - Strong Feelings - Latest Findings On Pain Sensitivity By : Anesthetics News
The recent discovery of the amplification of even low levels of pain has prompted the organisation of an upcoming symposium in Vienna on "Risk Assessment in Pain Therapy". This international expert meeting will aim to optimise pain therapy by taking account of this previously unknown phenomenon. As a result the findings of an Austrian Science Fund FWF project, which were recently published in SCIENCE, may soon be benefiting patients who suffering severe chronic pain. - Alternative Therapies Affect Experience Of Chronic Pain By : Anesthetics News
A significant number of people world-wide suffer with chronic pain, which affects every aspect of their lives, and often results in depression. - Back Pain, Injuries and Work Loss Considered By : Lance Winslow
Have you ever woken up when you slept wrong and your neck hurts like holy hell? Well those who have back pains describe their pains the same way. Imagine trying to do all you do, every day with this sort of pain in your back? - Back Exercises Can Help Ease Back Pain By : Andy Green
A lot of people are mistaken when think that back exercises should be avoided if you have pain in your back. Of course it is understandable -- people are afraid of stretching and damaging back and aggravating the pain. However for the most problems with the back the natural healing process is exercise. - NMT Medical Receives FDA Approval To Modify MIST II PFO Migraine Study In The United States By : Migraine News
NMT Medical, Inc. (Nasdaq: NMTI) announced today that it has received conditional approval from the U.S. Food and Drug Administration (FDA) for modifications the Company requested to its current investigational device exemption (IDE) for its pivotal PFO (patent foramen ovale)/migraine clinical study, MIST II. The changes are supported by the Company's previous trials -- MIST and BEST (BioSTAR(R) Evaluation STudy). - http://www.content.onlypunjab.com/myarticle.php By : Migraine News
MAP Pharmaceuticals announced today the initiation and first patient dosing of a Phase 2 clinical trial evaluating MAP0004 for the treatment of acute migraine headaches. MAP0004 is a novel inhaled drug formulation of dihydroergotamine mesylate (DHE) administered with MAP's patented Tempo(TM) Inhaler. The therapy is intended to offer fast onset of action similar to an IV infusion, but without the need for an injection in a hospital or doctor's office setting. - NeurogesX Extension Study Indicates Repeat Treatment with Transacin Provides Prolonged Pain By : Health News
NeurogesX, Inc., a privately held specialty pharmaceutical company, presented results from an open-label 40-week extension study in painful HIV-associated neuropathy (HIV-AN) patients that indicated repeat treatment with Transacin(TM) (NGX-4010) resulted in consistent reductions in pain over the entire 52-week study period. - Tips To Get Relief From Chronic Back Pain By : Javier Fuller
- Find a Chiropractor By : Scott Larsen
- Natural Back Pain Relief By : Javier Fuller
- Simply And Naturally: End Your Back Or Rheumatoid Joint Pain By : Brenda Skidmore
- Cancer Patients Show Reduced Pain And Lower Analgesic Consumption Following Treatment By : Anesthetics News
Cytogen Corporation (Nasdaq: CYTO) today announced the publication of new data relating to the Company's QUADRAMET(R) (samarium Sm-153 lexidronam injection) product. The publication, "Incident pain and analgesic consumption decrease after samarium infusion: a pilot study" appears in a recent issue of the peer-reviewed journal Supportive Care in Cancer (Support Care Cancer. 2006 Sep 12). - Vernalis Plc Announces FDA Acceptance For Filing Of Frova(R) For Short-Term Prevention Of Menstrual By : Migraine News
Vernalis plc (LSE: VER, Nasdaq: VNLS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing the supplemental New Drug Application (sNDA) for Frova(R) (frovatriptan succinate) 2.5 mg tablets for the short-term (six days per month) prevention of menstrual migraine (MM). - New Analysis Shows Patients Who Treat Their Migraine Pain Early With Trexima(TM) By : Migraine News
Migraine sufferers frequently cite lack of recurrence of migraine symptoms as one of the most desired attributes of an acute migraine treatment. Now, a new analysis of four studies showed that patients who treated their migraines with Trexima while pain was mild and within one hour of the start of pain were nearly twice as likely to be pain free at 2 hours, and remain pain free through 24 hours, than those who waited until the pain was more severe. - Is Your Throbbing Back Pain Causing You Alarm? By : Steven Resell
A lot of people live with intense back pain, yet never look at some of the alternative lower back pain treatments. If you are still popping pain medication for months at a time, then you may want to take a gander and see if alternative back pain treatments are suitable for you. - Upper Back Pain By : Javier Fuller
Upper back pain is not as common as the lower back pain. But pain is pain. When the pain process starts, it is unbearable. The two common identified causes of upper back pain are muscular irritation and joint dysfunction. - New Data Show Consistent Efficacy And Tolerability Of Trexima™ (sumatriptan Succinate/naproxen By : Migraine News
New data examining more than 4,200 migraine attacks in more than 1,100 patients demonstrated that Trexima delivered consistent efficacy over multiple migraine attacks. The findings, presented today at the 16th Migraine Trust International Symposium in London, suggest Trexima may address an unmet need among migraine sufferers, who frequently cite inconsistent effectiveness as a reason for their dissatisfaction with their medicine. - How To Cure My Blood Pressure - Kidney Disease And Back Pain All Together By : Javier Fuller
If you have back pain that doesn't mean that you have kidney disease. But if you have kidney disease, certainly you have back pain! But the trouble with the kidney disease is that it attacks you silently. - The Growing Epidemic of Low Back Pain in Children By : Dr. Brenda Slovin
In years past, low back pain was thought to be a malady afflicting only the elderly. Well, it’s not just your granddad’s disorder any longer. Once considered a rare pediatric condition, low back pain in children has become a growing concern among many in the medical community. - States Improve Pain Policies, But Barriers Remain To Effective Pain Management For Cancer By : Anesthetics News
States are making steady progress in adopting effective policies that help people with pain to alleviate their suffering, according to a newly released national report card. However, there are still states with policies that prevent healthcare professionals from effectively alleviating the suffering of their patients. - Neck Pain-Emerging Complaints By : Rob Tworek
Emerging complaints of neck pain. The necessity of prevention information to reduce the risk of developing neck injury. - Are Chiropractors Afraid of the Internet? By : Scott Larsen
This idea comes from many conversations with chiropractors about gaining new clients via the internet. It is written specifically with chiropractors in mind hopefully clears up some myths concerning internet marketeering for chiropractors. - Alpharma Announces Positive Results From A Phase II Safety, Efficacy And Pharmacokinetic By : Anesthetics News
Alpharma Inc. (NYSE: ALO), a leading, global specialty pharmaceutical company, today announced ºpositive results from a Phase II multi-dose clinical efficacy and pharmacokinetic trial for its abuse-deterrent, extended-release opioid. The goal of this study was to demonstrate that Alpharma's proprietary abuse- deterrent technology for long-acting opioids does not impact the safety or efficacy of the product. - Patients With Migraine Headaches Tested With Spinal Cord Stimulators By : Migraine News
Researchers at Rush University Medical Center are testing a new treatment for migraine headaches: occipital nerve stimulation, a surgical procedure in which an implanted neurostimulator delivers electrical impulses to nerves under the skin at the base of the head at the back of the neck. - Five Tips for Preventing Back Pain in Office Workers By : S. L. Simmons
Sitting in the same position at your desk day after day can be bad for your back. Follow these tips to help keep your back strong, healthy and pain free. - September Marks Movement In National Pain Policy, USA By : Anesthetics News
September has been an active month for efforts to achieve a balanced pain policy. On September 6, the Drug Enforcement Administration published two documents in the Federal Register long awaited by the pain treatment community. In addition, DEA Administrator Karen Tandy reaffirmed the agency's support for a joint statement on pain policy involving 21 health organizations and the DEA in 2001. - Why Can Acupuncture Be The Right Form Of Alternative Treatment? By : Allison Thompson
This article explains why acupuncture is a good form of alternative natural treatment for dealing with many illnesses and ailments in today's society. - UCB And Jazz Pharmaceuticals Announce Expansion Of Xyrem(R)License Agreement To Include Fibromyalgia By : Anesthetics News
UCB(Euronext Brussels: UCB) and Jazz Pharmaceuticals, Inc. today announced the signing of an expanded product license agreement for Xyrem(R) (sodium oxybate). - Steroid Injections Do Not Provide Long-term Relief From Tennis Elbow: Study Shows By : Anesthetics News
Physiotherapy or a "wait and see" approach are both more effective in tackling tennis elbow than corticosteroid (steroid) injections, according to a UQ study published in the British Medical Journal. - What's the Best Way to Sleep? By : Daniel DeReuter
Techniques for sleeping by a chiropractor that you can use to sleep better and more soundly. - Millions Live With Painful GI Symptoms Impacting Their Lives, But Sufferers Rarely Discuss Symptoms By : Anesthetics News
While more than 20 million Americans live with the painful and disruptive ABC symptoms -- Abdominal pain or discomfort, Bloating and Constipation -- many do not discuss all their symptoms with their doctors and even fewer are able to find complete relief, according to results of a new Roper ASW survey released today by RealAge, Inc., a leader in personalized health and wellness information. - Common causes of Back Pain By : Lenore Chapman
Most back pain are the result of repeated physical stress or on going conditions. Pain can occur anywhere along the back, but mostly in the lower back. - Acupressure Cures Back Pain For Sure By : Javier Fuller
The natural and therapeutic therapies such as Acupressure and Massage therapy are the recommended options for seeking back pain relief. Well, these therapies offer you the immediate and permanent back pain cure. - Lower Back Pain Relief - Simple Ways To Eliminate Lower Back Pain By : Paul Osborne
Lower back pain relief can be achieved in a variety of ways, but firstly it is important to find get an accurate diagnosis for your particular ailment, so that lower back pain relief can be correctly administered. - Using an Electric Massage Chair By : Christain Cullen
Owning an electric massage chair will easily and quickly pay for itself in the fact that you will be enjoying your life more because of your ability to relax.Using an electric massage chair is the next big luxury fad. - Alternative Treatment: The Best Option For Back Pain Relief By : Javier Fuller
With the failure of most of the over the counter and prescription medications to find the cure for back pain, the alternative medicine has taken the center stage. One of the finest advantages of these systems is that there are no harmful side effects. - Why Buy an Adjustable Bed? By : Nicole Martins
Spending the night awake or waking up feeling sore certainly takes the joy out of sleeping. And since we spend 1/3 of our lives in bed sleeping or trying to do so, a comfortable mattress and bed is essential. - Halozyme Therapeutics Completes Enrollment Of Infuse-Morphine Clinical Trial By : Anesthetics News
Halozyme Therapeutics, Inc. (Amex: HTI), a biopharmaceutical company developing and commercializing recombinant human enzymes, today announced it has completed enrollment of a clinical trial of subcutaneous administration of morphine with Hylenex. Hylenex is a liquid injectable formulation that includes the active pharmaceutical ingredient, recombinant human hyaluronidase (rHuPH20). - Venomous Cone Snail Biologist Named To Institute Of Medicine By : Anesthetics News
Baldomero "Toto" Olivera - a University of Utah biologist who seeks new medications from the toxins of poisonous cone snails - won one of medicine's top honors Monday when he was named as a new member of the Institute of Medicine. - Antinociceptive Effect Of Linear Polarized 0.6 To 1.6 m Irradiation Of Lumbar Sympathetic Ganglia By : Anesthetics News
Linear polarized near-infrared light has been used to treat various painful disorders. We examinedthe effects of irradiation applied to an area near the lumbar sympathetic ganglia on the ligated side in a chronic constriction injury model in rats, which is believed to be an animal model of complex regional pain syndrome (CRPS). - Cephalon Announces Positive Results For FENTORA(TM) (fentanyl Buccal Tablet) For Breakthrough Pain By : Anesthetics News
Cephalon, Inc. (Nasdaq: CEPH) today announced that data from a Phase 3 clinical trial of FENTORA(TM) (fentanyl buccal tablet) [C-II] demonstrate efficacy in the management of breakthrough pain in opioid-tolerant patients with chronic low back pain. - Using Cranial Electrotherapy Stimulation To Treat Pain Associated With Spinal Cord Injury By : Anesthetics News
Cranial electrotherapy stimulation (CES) sends microcurrents to the brain via electrodes clipped to the ears. CES can effectively treat spinal, head, dental, and muscle pain and control conditions associated with pain (anxiety, depression, insomnia, and stress). - Are Patient Ratings Of Chronic Pain Services Related To Treatment Outcome? By : Anesthetics News
We examined the relationships between ratings of services and outcomes of patients who received pain treatment at a teaching hospital. A group of 122 patients who completed a multidisciplinary pain-management program rated their satisfaction with and the effectiveness of services as well as changes in their pain condition and quality of life. - Anesiva Announces That FDA Grants Orphan Drug Status For Pain Drug 4975 To Treat Interdigital By : Anesthetics News
Anesiva, Inc. (Nasdaq: ANSV) announced today that the U.S. Food and Drug Administration (FDA) granted orphan drug status to product candidate 4975 for the treatment of a painful condition in the foot known as interdigital neuroma in patients who fail conservative treatments, such as foot pads, NSAID's (non-steroidal anti-inflammatory drugs) and injections of corticosteroids, that would otherwise require removing or chemically destroying the nerve that causes the pain. - How To Acquire Complete Back Pain Cure? By : Javier Fuller
Though there are many over the counter medications for the back pain in general, you can't say that it is your medicine as well. The cause and specific conditions relating to the back pain vary from individual to individual. - New River Pharmaceuticals Conducts End-of-Phase II Meeting With FDA For NRP290 By : Anesthetics News
New River Pharmaceuticals Inc. (Nasdaq: NRPH) announced today that company officials conducted an end- of-phase II meeting on Thursday with staff members of the Center for Drug Evaluation and Research of the U.S. Food and Drug Administration to discuss NRP290, under development as a potential treatment for acute pain. A derivative of hydrocodone, NRP290 has undergone two pharmacokinetic clinical studies. - How a Memory Foam Mattress can Make you Feel Like a Teenager Again By : Amy-Jo Strutt
This article will clearly outline the advantages of memory foam mattresses and pillows. - Adopt Correct Postures To Get Rid Of Back Pain By : Javier Fuller
Back pain can affect an individual in many ways. Apart from the sheer physical discomfort of not being able to sit, stand, walk or even move a few steps conveniently, there are even deeper and more sinister results of back pain. - The Rheumatologist To Be Launched By American College Of Rheumatology And Wiley By : Anesthetics News
Global publisher John Wiley & Sons, Inc., and the American College of Rheumatology (ACR) today announced an agreement to launch The Rheumatologist, a new controlled-circulation newsmagazine that will provide breaking news and information to rheumatology and rheumatologist health professionals in a unique and visually compelling format. - Columbus Ohio Chiropractic By : Scott Larsen
There are more than 1000 chiropractors in the Columbus Ohio area. If you are looking for a new D.C. to visit here are a few easy steps. Don’t give up, if you need a chiropractor shop around until you find one that fits you needs. - How Well Does Exercises For Low Back Pain Work? By : Javier Fuller
As for the exercises for back pain, there is only one of the rare agreements between all the parties concerned. You must do proper physical exercises! There are many such exercises, yoga exercises in particular. - Get Lower Back Pain Relief After Knowing Its Cause By : Javier Fuller
No single cause for lower back pain can be defined in isolation. It is because the types of back pains are many. Understand the pain in its proper perspective, and then decide about the type of treatment that you intend to pursue. In the USA, the survey reports indicate that four out of five adults experience back pain at one time or the other during their lives. - Top 10 Tips for Curing Back Pain By : Joanne Gresham
Top tips for back pain sufferers - natural cure with no drugs, no gadgets, no surgery - Passfaces™ Online Authentication Company Signs Partnership Agreement with Thornberry Ltd. By : Health News
Passfaces Corporation and Thornberry Ltd. today announced a strategic partnership agreement under which Thornberry Ltd. will integrate Passfaces patented authentication product into its existing information management software to enable healthcare clients to further strengthen HIPAA privacy and security requirements by augmenting existing passwords. - TorreyPines Therapeutics Initiates Phase IIb Clinical Trial In Acute Migraine For Lead Compound By : Anesthetics News
TorreyPines Therapeutics, Inc. (Nasdaq: TPTX) today announced the initiation of a Phase IIb clinical trial for its lead product candidate, tezampanel, a novel pain compound in development for the treatment of acute migraine. An AMPA/kainate (AK) receptor antagonist, tezampanel offers a non-narcotic, non-vascular approach to the management of headache pain and represents a potentially promising alternative to current migraine treatments. - Pegasus Technologies Innovative Use of CRYPTOCard's Authentication Tokens Saves Lower Colorado River By : Health News
Pegasus Technologies (www.pegasustechnologies.com), a leader in IT-based security solutions and services, is proud to announce that its innovative deployment of CRYPTOCard’s (www.cryptocard.com) user-friendly two-factor authentication tokens has enabled Lower Colorado River Authority (LCRA) to positively identify field workers by phone during the critical “Red Tagging” process – instantly eliminating 60 percent of associated travel time. - Prescription Pain Medication Abuse On Surprising Increase, With Unexpected Geographic Distribution By : Anesthetics News
Researchers at Rush University Medical Center found prescription pain medication (PPM) abuse is a rapidly growing problem with surprising and often unpredictable distribution patterns. The research was presented at the Annual Meeting of the American Society for Anesthesiologists in Chicago, October 13, 2006. - Prescription Medication For Back Pain Relief By : Aasheesh Jain
Your doctor is your friend. When dealing with the back pain follow your friend's advice with heart. Don't recognize your medicinal pills by their color only. Know their qualities. Question your doctor unhesitatingly about the medicine contents. - Top Tips For Back Pain Relief By : Aasheesh Jain
Intelligent management of your body mechanism is the best answer to your back pain. Well, it woks for back pain of all types. Here is a quick list of tips to get relief from back pain. - New Guidelines For Postoperative Nausea And Vomiting By : Anesthetics News
After five years of reviewing the latest research findings, a panel of experts led by a Duke University Medical Center anesthesiologist has developed new guidelines to help physicians reduce the occurrence of nausea and vomiting in patients after surgery. - Brain Changes In Patients With Migraine By : Migraine News
Researchers from Harvard Medical School have found increased thickness of two areas of the brain cortex in people with migraine when compared to healthy controls. Both areas of the brain are known to be involved in how the brain processes signals to do with movement. - Brain's"'Pleasure Chemical" Is Involved In Response To Pain Too, Study Shows By : Anesthetics News
For years, the brain chemical dopamine has been thought of as the brain's "pleasure chemical," sending signals between brain cells in a way that rewards a person or animal for one activity or another. More recently, research has shown that certain drugs like cocaine and heroin amplify this effect - an action that may lie at the heart of drug addiction. - Anesthesia Choices For C-Section Lead To Similar Outcomes For Mother And Baby By : Anesthetics News
The review found little significant difference with respect to major clinical outcomes -- although some women had lower blood counts and shivering after C-section with general anesthesia and some experienced more nausea and vomiting with regional anesthesia. - Knee Pain And Reliance On Painkillers Can Be Reduced With Help From Physiotherapists And Pharmacists By : Anesthetics News
Older people with knee pain who receive their main care from physiotherapists and pharmacists are more likely to experience improvements in pain levels and knee function, and are less likely to need NSAIDs (non-steroidal anti-inflammatory drugs, eg asprin and ibuprofen), according to a BMJ study. - Back Pain--when To See A Doctor By : Anesthetics News
Some 70%-80% of men (and nearly as many women) have endured a bout of moderate to severe back pain. And the problem goes well beyond pain and inconvenience; the annual cost of medical care and lost productivity is more than $50 billion.
|
